US Launches Trade Probe into Germany’s Drug Pricing Policies
Germany’s Drug Pricing Under US Scrutiny The United States has opened a Section 301 trade investigation into Germany’s pharmaceutical pricing
Continue ReadingJune 19, 2026
Germany’s Drug Pricing Under US Scrutiny The United States has opened a Section 301 trade investigation into Germany’s pharmaceutical pricing
Continue Reading